PRPF38B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.589600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.444400E-01
Normal-vs-Stage2
3.672600E-01
Normal-vs-Stage3
2.174000E-01
Normal-vs-Stage4
5.895200E-01
Stage1-vs-Stage2
6.185200E-01
Stage1-vs-Stage3
6.453700E-02
Stage1-vs-Stage4
3.500000E-01
Stage2-vs-Stage3
6.206400E-04
Stage2-vs-Stage4
7.111700E-02
Stage3-vs-Stage4
4.106500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.592400E-01
Normal-vs-AfricanAmerican
2.707400E-01
Normal-vs-Asian
3.036000E-01
Caucasian-vs-AfricanAmerican
5.785600E-01
Caucasian-vs-Asian
2.942200E-01
AfricanAmerican-vs-Asian
3.547600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.512800E-01
Normal-vs-Female
3.684000E-01
Male-vs-Female
6.043600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.084400E-01
Normal-vs-Age(41-60Yrs)
4.378800E-01
Normal-vs-Age(61-80Yrs)
3.315200E-01
Normal-vs-Age(81-100Yrs)
2.991000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.446800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.581200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.070800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.643600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.775500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.909600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.368000E-01
Normal-vs-Daily Drinker
2.951800E-01
Normal-vs-Weekly Drinker
3.013800E-01
Normal-vs-Occasional Drinker
3.750400E-01
Normal-vs-Social Drinker
3.833200E-01
Non Drinker-vs-Daily Drinker
3.967600E-01
Non Drinker-vs-Weekly Drinker
5.075600E-01
Non Drinker-vs-Occasional Drinker
4.901800E-01
Non Drinker-vs-Social Drinker
4.888800E-01
Daily Drinker-vs-Weekly Drinker
9.206400E-01
Daily Drinker-vs-Occasional Drinker
1.432590E-01
Daily Drinker-vs-Social Drinker
1.755370E-01
Weekly Drinker-vs-Occasional Drinker
1.804610E-01
Weekly Drinker-vs-Social Drinker
2.249600E-01
Occasional Drinker-vs-Social Drinker
9.262000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.455400E-01
Normal-vs-Grade 2
2.614000E-02
Normal-vs-Grade 3
4.273600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.012600E-01
Grade 1-vs-Grade 3
3.975200E-01
Grade 1-vs-Grade 4
2.455400E-01
Grade 2-vs-Grade 3
5.309800E-01
Grade 2-vs-Grade 4
2.614000E-02
Grade 3-vs-Grade 4
4.273600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.302800E-01
Normal-vs-NonDiabetic
3.314400E-01
Diabetic-vs-NonDiabetic
9.395200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.388800E-01
Normal-vs-NoPancreatitis
3.324200E-01
Pancreatitis-vs-NoPancreatitis
9.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.482400E-01
Normal-vs-N1
3.717000E-01
N0-vs-N1
4.913600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.656200E-01
Normal-vs-TP53-NonMutant
3.623000E-01
TP53-Mutant-vs-TP53-NonMutant
9.409600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
